Carbidopa and Levodopa Enteral Suspension and Sodium Phenylbutyrate Powder
Determining the interaction of Carbidopa and Levodopa Enteral Suspension and Sodium Phenylbutyrate Powder and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: carbidopa / levodopa
Brand name: Parcopa, Rytary, Sinemet, Sinemet CR, Duopa
Synonyms: Carbidopa and levodopa, Carbidopa and Levodopa
Generic Name: sodium phenylbutyrate
Brand name: Buphenyl
Synonyms: Sodium phenylbutyrate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Carbidopa and Levodopa Enteral Suspension-Sodium Phenylbutyrate Tablets
- Carbidopa and Levodopa Enteral Suspension-Sodium phosphate dibasic and sodium phosphate monobasic
- Carbidopa and Levodopa Enteral Suspension-Sodium phosphate dibasic and sodium phosphate monobasic Rectal
- Carbidopa and Levodopa Enteral Suspension-Sodium phosphate p 32 Intravenous
- Carbidopa and Levodopa Enteral Suspension-Sodium Phosphates
- Carbidopa and Levodopa Enteral Suspension-Sodium Phosphates Enema
- Sodium Phenylbutyrate Powder-Carbidopa and Levodopa Extended-Release Capsules
- Sodium Phenylbutyrate Powder-Carbidopa and Levodopa Extended-Release Tablets
- Sodium Phenylbutyrate Powder-Carbidopa and Levodopa ODT
- Sodium Phenylbutyrate Powder-Carbidopa and Levodopa Orally Disintegrating Tablets
- Sodium Phenylbutyrate Powder-Carbidopa and levodopa Route Not Applicable
- Sodium Phenylbutyrate Powder-Carbidopa and Levodopa Tablets